Class II
Ongoing
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road…
Why: Subpotent Drug
- Company
- ACCORD HEALTHCARE, INC.
Raleigh, NC, United States - Reported
- Jul 8, 2026
- Recall started
- Jun 8, 2026
- Where sold
- US Nationwide.
- Amount
- 6432 bottles
- Full product description
- Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
- Lots / codes affected
- Lot # D2401522, Exp Date: 06/2026.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.